Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher D. Alafi currently holds 95,000 shares of Intra-Cellular Therapies, Inc. (ITCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher D. Alafi has been a net buyer of ITCI stock. They have purchased $43.6M and sold $4.0M worth of shares.
Christopher D. Alafi's most recent insider trade was on May 28, 2021, when they sold 38,843 shares at $40.12 per share.
Christopher D. Alafi serves as Executive at Intra-Cellular Therapies, Inc. (ITCI). They have executed 147 insider transactions totaling $47.6M over their tenure at the company.
Christopher D. Alafi holds the position of Executive at Intra-Cellular Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Christopher D. Alafi has shown a buying trading pattern, with $43.6M in total purchases and $4.0M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Christopher D. Alafi was on Mar 11, 2015, when they purchased $15.0M worth of ITCI shares. This transaction involved 625,000 shares at $24.00 per share.
Christopher D. Alafi currently owns 95,000 shares of Intra-Cellular Therapies, Inc. (ITCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher D. Alafi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher D. Alafi has 147 Form 4 filings on record as an insider at Intra-Cellular Therapies, Inc..
Set alerts for Christopher D. Alafi and 40,000+ other insiders.